GOLDCASE vs MAXHEALTH: Stock Comparison

Head-to-head financial and trading comparison between GOLDCASE (GOLDCASE) and Max Healthcare Institute Limited (MAXHEALTH) in the Cross-Sector Peers sector.

GOLDCASE

NSE: GOLDCASE
GOLDCASE
₹23.35
1Y Return: -1.85%
52W High: ₹25.33
52W Low: ₹21.82
Annual Volatility: 17.92%
Check GOLDCASE Trade Fees →

MAXHEALTH

NSE: MAXHEALTH
Max Healthcare Institute Limited
₹883.80
1Y Return: -12.61%
52W High: ₹1,153.40
52W Low: ₹873.40
Annual Volatility: 31.96%
Check MAXHEALTH Trade Fees →

Key Metrics Comparison Table

MetricGOLDCASEMAXHEALTHEdge / Winner
Current Market Price (CMP) ₹23.35 ₹883.80 —
1-Year Price Return -1.85% -12.61% GOLDCASE (10.76% higher)
52-Week High ₹25.33 ₹1,153.40 —
52-Week Low ₹21.82 ₹873.40 —
30-Day Annualized Volatility 17.92% 31.96% GOLDCASE (Steadier)
30-Day Average Daily Volume 12,964,735 2,642,110 GOLDCASE (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between GOLDCASE and MAXHEALTH, which stock gave better returns over the last year?

GOLDCASE has outperformed MAXHEALTH over the past 12 months with a gain of -1.85% compared to -12.61%.

Which stock is less volatile: GOLDCASE or MAXHEALTH?

GOLDCASE demonstrated lower price volatility (17.92% annualized) compared to MAXHEALTH (31.96%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of GOLDCASE vs MAXHEALTH?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are GOLDCASE and MAXHEALTH direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.